Novavax (NVAX) Gross Margin Growth (1y) (2012 - 2026)
Novavax (NVAX) Gross Margin Growth (1y) (2012 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 372.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | -5.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -165.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 236.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Novavax | 788.01 Mn | -2.33 Mn | 108.82 Mn | -1,988.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1,988.00 |
| Dec 31, 2025 | 2,650.00 |
| Sep 30, 2025 | 4,121.00 |
| Jun 30, 2025 | 237.00 |
| Mar 31, 2025 | 6,097.00 |
| Dec 31, 2024 | 1,167.00 |
| Sep 30, 2024 | -1,882.00 |
| Jun 30, 2024 | 201.00 |
| Mar 31, 2024 | -2,098.00 |
| Dec 31, 2023 | -234.00 |
| Sep 30, 2023 | 626.00 |
| Jun 30, 2023 | 13,266.00 |
| Mar 31, 2023 | -3,995.00 |
| Dec 31, 2022 | -5,086.00 |
| Sep 30, 2022 | -5,916.00 |
| Jun 30, 2022 | -14,580.00 |
| Mar 31, 2022 | -216.00 |
| Sep 30, 2015 | 693.00 |
| Jun 30, 2015 | 4,258.00 |
| Mar 31, 2015 | 1,559.00 |